Adicet Bio, Inc. (ACET)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-05) · 99.1 | ||
| 10-K/A | FY-2025 | |||
| 10-Q | Q1-2026 | 8-K (2026-05-13) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-12) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-05) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-07) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-06) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-06) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-06) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-13) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-14) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-19) · 99.1 | 8-K (2024-01-24) · 99.1 · 99.2 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-08) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (deficit) | — |
|
| Consolidated Statements of Stockholders' Equity (deficit) | — |
|
| Consolidated Statements of Stockholders' Equity (unaudited) | — |
|
| Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (deficit) (P) | — |
|
| Consolidated Statements of Stockholders' Equity (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accrued and Other Current Liabilities | ||
| Commitments and Contingences | ||
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Defined Contribution Plan | — |
|
| Fair Value Measurements | ||
| Goodwill | — |
|
| Goodwill Impairment | — |
|
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Marketable Debt Securities | — |
|
| Marketable Securities | ||
| Net Loss Per Share | ||
| Organization and Nature of Business | ||
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses and Other Current Assets | ||
| Property and Equipment, Net | ||
| Related Party | — |
|
| Related Party Transactions | — |
|
| Restricted Cash | ||
| Segment Reporting | ||
| Shanghai Adicet Biotechnology Co., Ltd. (the Adicet Vie) | ||
| Stock-based Compensation | ||
| Stockholders' Equity | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| Term Loan | ||
| Third Party Agreements | ||